Medical management of the hypercalcemia of malignancy.
D001859:Bone Neoplasms / Q000150:complications; D002116:Calcitonin / Q000627:therapeutic use; D002951:Citrates / Q000627:therapeutic use; D004492:Edetic Acid / Q000627:therapeutic use; D004976:Ethacrynic Acid / Q000008:administration & dosage / Q000627:therapeutic use; D005665:Furosemide / Q000008:administration & dosage / Q000627:therapeutic use; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D006934:Hypercalcemia / Q000188:drug therapy / Q000209:etiology; D007275:Injections, Intravenous; D009362:Neoplasm Metastasis; D009369:Neoplasms / Q000150:complications / Q000378:metabolism; D010281:Parathyroid Hormone / Q000378:metabolism / Q000502:physiology; D010710:Phosphates / Q000627:therapeutic use; D008926:Plicamycin / Q000627:therapeutic use; D006435:Renal Dialysis; D012965:Sodium Chloride / Q000627:therapeutic use; D013431:Sulfates / Q000627:therapeutic use; D014882:Water-Electrolyte Balance
D002951:Citrates; D005938:Glucocorticoids; D010281:Parathyroid Hormone; D010710:Phosphates; D013431:Sulfates; D012965:Sodium Chloride; D005665:Furosemide; D002116:Calcitonin; D004492:Edetic Acid; D004976:Ethacrynic Acid; D008926:Plicamycin